S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Stock ideas from the 2024 Microcap Conference
66,000% upside on tiny biotech? (Ad)
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
How major US stock indexes fared Friday, 2/23/2024
66,000% upside on tiny biotech? (Ad)
In his annual letter, Warren Buffett tells investors to ignore Wall Street pundits
MarketBeat Week in Review – 2/19 - 2/23
66,000% upside on tiny biotech? (Ad)
Closing prices for crude oil, gold and other commodities
Mark Zuckerberg Is Sitting on a Huge Stockpile of AI Chips as Companies Compete for Limited Supplies
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Stock ideas from the 2024 Microcap Conference
66,000% upside on tiny biotech? (Ad)
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
How major US stock indexes fared Friday, 2/23/2024
66,000% upside on tiny biotech? (Ad)
In his annual letter, Warren Buffett tells investors to ignore Wall Street pundits
MarketBeat Week in Review – 2/19 - 2/23
66,000% upside on tiny biotech? (Ad)
Closing prices for crude oil, gold and other commodities
Mark Zuckerberg Is Sitting on a Huge Stockpile of AI Chips as Companies Compete for Limited Supplies
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Stock ideas from the 2024 Microcap Conference
66,000% upside on tiny biotech? (Ad)
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
How major US stock indexes fared Friday, 2/23/2024
66,000% upside on tiny biotech? (Ad)
In his annual letter, Warren Buffett tells investors to ignore Wall Street pundits
MarketBeat Week in Review – 2/19 - 2/23
66,000% upside on tiny biotech? (Ad)
Closing prices for crude oil, gold and other commodities
Mark Zuckerberg Is Sitting on a Huge Stockpile of AI Chips as Companies Compete for Limited Supplies
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Stock ideas from the 2024 Microcap Conference
66,000% upside on tiny biotech? (Ad)
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
How major US stock indexes fared Friday, 2/23/2024
66,000% upside on tiny biotech? (Ad)
In his annual letter, Warren Buffett tells investors to ignore Wall Street pundits
MarketBeat Week in Review – 2/19 - 2/23
66,000% upside on tiny biotech? (Ad)
Closing prices for crude oil, gold and other commodities
Mark Zuckerberg Is Sitting on a Huge Stockpile of AI Chips as Companies Compete for Limited Supplies
NASDAQ:HOLX

Hologic (HOLX) Stock Price, News & Analysis

$76.15
+0.27 (+0.36%)
(As of 02/23/2024 ET)
Today's Range
$75.64
$76.48
50-Day Range
$70.32
$76.15
52-Week Range
$64.02
$87.88
Volume
1.42 million shs
Average Volume
2.00 million shs
Market Capitalization
$17.87 billion
P/E Ratio
36.09
Dividend Yield
N/A
Price Target
$86.89

Hologic MarketRank™ Stock Analysis

Analyst Rating
Hold
2.38 Rating Score
Upside/​Downside
14.1% Upside
$86.89 Price Target
Short Interest
Healthy
1.94% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.59
Upright™ Environmental Score
News Sentiment
1.01mentions of Hologic in the last 14 days
Based on 17 Articles This Week
Insider Trading
Selling Shares
$1.81 M Sold Last Quarter
Proj. Earnings Growth
8.46%
From $4.02 to $4.36 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.67 out of 5 stars

Medical Sector

60th out of 939 stocks

X-Ray Apparatus & Tubes Industry

1st out of 1 stocks


HOLX stock logo

About Hologic Stock (NASDAQ:HOLX)

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

HOLX Stock Price History

HOLX Stock News Headlines

SHOCKING Crypto Leak Reveal Crypto's Set To SURGE
A shocking leak has revealed tech giant Microsoft plans to add crypto support to future products. If the plans in these leaked documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, and MORE. The coupling of gaming and cryptocurrency could transform digital finance as we know it. We've gathered 27 experts to share their top picks and predictions for the 2024 crypto bull run.
Calculating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)
Hologic (NASDAQ:HOLX) Downgraded to Hold at StockNews.com
HOLX Mar 2024 50.000 put
HOLX Mar 2024 70.000 put
Hologic, Inc.
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN?
Financial giants have been injecting millions into the crypto market. The big players are going all in on crypto… but what are they gearing up for? There is a significant event on the horizon that will shape the future of Bitcoin—the upcoming Bitcoin halving event…We're revealing all the secrets behind the financial elite's bold moves in crypto during our LIVE, online event.
Hologic: Prospects For Growth As Headwinds Disappear
Hologic First Quarter 2024 Earnings: Beats Expectations
Hologic price target raised by $2 at Morgan Stanley, here's why
Hologic: Hold Rating Justified by Solid Performance and Fair Valuation
Q1 2024 Hologic Inc Earnings Call
Recap: Hologic Q1 Earnings
Hologic Inc Q1 Profit Increases, beats estimates
See More Headlines
Receive HOLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hologic and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/01/2024
Today
2/24/2024
Next Earnings (Estimated)
5/06/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
X-ray apparatus & tubes
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:HOLX
CUSIP
43644010
Employees
6,990
Year Founded
1985

Price Target and Rating

Average Stock Price Target
$86.89
High Stock Price Target
$105.00
Low Stock Price Target
$72.00
Potential Upside/Downside
+14.1%
Consensus Rating
Hold
Rating Score (0-4)
2.38
Research Coverage
8 Analysts

Profitability

Net Income
$456 million
Pretax Margin
15.83%

Debt

Sales & Book Value

Annual Sales
$4.03 billion
Cash Flow
$5.36 per share
Book Value
$19.83 per share

Miscellaneous

Free Float
230,624,000
Market Cap
$17.87 billion
Optionable
Optionable
Beta
1.02

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Should I Buy Hologic Stock? HOLX Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Hologic was last updated on Tuesday, February 20, 2024 at 3:25 PM.

Pros

Here are some ways that investors could benefit from investing in Hologic, Inc.:

  • Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health, which is a growing market segment with increasing demand.
  • Recent developments in the company's product portfolio have shown innovation and competitiveness in the healthcare industry.
  • Hologic, Inc. has a strong distribution network that includes healthcare facilities, resources, independent distributors, and sales representatives, providing a wide reach for its products.
  • The current stock price of Hologic, Inc. is competitive and shows potential for growth based on recent financial performance.

Cons

Investors should be bearish about investing in Hologic, Inc. for these reasons:

  • While the company has shown innovation, there may be risks associated with new product development and market acceptance.














HOLX Stock Analysis - Frequently Asked Questions

Should I buy or sell Hologic stock right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Hologic in the last twelve months. There are currently 5 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" HOLX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HOLX, but not buy additional shares or sell existing shares.
View HOLX analyst ratings
or view top-rated stocks.

What is Hologic's stock price target for 2024?

8 analysts have issued 1 year target prices for Hologic's shares. Their HOLX share price targets range from $72.00 to $105.00. On average, they predict the company's stock price to reach $86.89 in the next twelve months. This suggests a possible upside of 14.1% from the stock's current price.
View analysts price targets for HOLX
or view top-rated stocks among Wall Street analysts.

How have HOLX shares performed in 2024?

Hologic's stock was trading at $71.45 at the beginning of 2024. Since then, HOLX shares have increased by 6.6% and is now trading at $76.15.
View the best growth stocks for 2024 here
.

Are investors shorting Hologic?

Hologic saw a decline in short interest in the month of January. As of January 31st, there was short interest totaling 4,490,000 shares, a decline of 20.1% from the January 15th total of 5,620,000 shares. Based on an average daily trading volume, of 1,930,000 shares, the short-interest ratio is currently 2.3 days. Approximately 1.9% of the shares of the stock are sold short.
View Hologic's Short Interest
.

When is Hologic's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 6th 2024.
View our HOLX earnings forecast
.

How were Hologic's earnings last quarter?

Hologic, Inc. (NASDAQ:HOLX) posted its quarterly earnings data on Thursday, February, 1st. The medical equipment provider reported $0.98 earnings per share for the quarter, beating analysts' consensus estimates of $0.95 by $0.03. The medical equipment provider had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $989.32 million. Hologic had a net margin of 12.98% and a trailing twelve-month return on equity of 18.91%. The company's quarterly revenue was down 5.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.07 EPS.
Read the conference call transcript
.

What guidance has Hologic issued on next quarter's earnings?

Hologic issued an update on its FY 2024 earnings guidance on Thursday, February, 1st. The company provided EPS guidance of 3.970-4.120 for the period, compared to the consensus EPS estimate of 4.000. The company issued revenue guidance of $4.0 billion-$4.1 billion, compared to the consensus revenue estimate of $4.0 billion.

What is Steve MacMillan's approval rating as Hologic's CEO?

447 employees have rated Hologic Chief Executive Officer Steve MacMillan on Glassdoor.com. Steve MacMillan has an approval rating of 79% among the company's employees. 81.0% of employees surveyed would recommend working at Hologic to a friend.

What other stocks do shareholders of Hologic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hologic investors own include AbbVie (ABBV), NVIDIA (NVDA), Johnson & Johnson (JNJ), Alibaba Group (BABA), Walt Disney (DIS), PayPal (PYPL), Advanced Micro Devices (AMD), CVS Health (CVS), Pfizer (PFE) and Abbott Laboratories (ABT).

Who are Hologic's major shareholders?

Hologic's stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (11.79%), Victory Capital Management Inc. (2.15%), Price T Rowe Associates Inc. MD (1.51%), Norges Bank (1.30%), Parnassus Investments LLC (1.23%) and Northern Trust Corp (1.15%). Insiders that own company stock include Benjamin Jordan Cohn, Essex D Mitchell, Jan Verstreken, John M Griffin, Karleen Marie Oberton, Scott T Garrett, Sean S Daugherty and Sean S Daugherty.
View institutional ownership trends
.

How do I buy shares of Hologic?

Shares of HOLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Hologic have any subsidiaries?
The following companies are subsidiares of Hologic: Acessa Health, Acessa Health Inc., Beijing Hologic Technology Co. Ltd., Benassar Diagnostica-Equipamientos Medicos Unipessoal Lda., BioLucent, BioLucent LLC, Bioptics Inc., Biotheranostics Inc, Biotheranostics Inc., Bolder Surgical, Cynosure, Cytyc, Cytyc Corporation, Cytyc Prenatal Products Corp., Cytyc Surgical Products LLC, Diagenode Co. Ltd., Diagenode LLC, Diagenode SA, Diagenode SA., Diagenode SPA, Direct Radiography Corp., Emsor Sociedad de responsabilidad limitada, Faxitron Bioptics, Faxitron Bioptics LLC, Focal Therapeutics, Gen-Probe, Gen-Probe Incorporated, Gen-Probe Prodesse Inc., Gen-Probe Sales & Service Inc., Genewave SAS, Health Beacons Inc, Health Beacons Inc., Hologic (Australia & New Zealand) Pty Ltd., Hologic (MA) LLC, Hologic (Shanghai) Medical Supplies Co. Ltd., Hologic ASE LLC, Hologic Asia Limited, Hologic Asia Pacific Limited, Hologic Austria GmbH, Hologic BV, Hologic Bermuda Limited, Hologic Canada ULC, Hologic Caribbean (Barbados) SRL, Hologic Denmark ApS, Hologic Deutschland GmbH, Hologic Espana S.A., Hologic Finance Ltd., Hologic France SARL, Hologic GGO 2 LLC, Hologic GGO 3 LLP, Hologic GGO 4 LTD, Hologic Global Holding LTD, Hologic HUB LTD, Hologic Hitec-Imaging, Hologic Hitec-Imaging GmbH, Hologic Holdings Limited, Hologic IP LTD, Hologic Iberia S.L., Hologic India LLP, Hologic International Holdings B.V., Hologic Ireland Limited, Hologic Italia S.r.l., Hologic Japan KK, Hologic Latin America (Servicos Em Marketing E Negocios) Ltda., Hologic Ltd., Hologic Malaysia SDN. BHD., Hologic Medical Technologies (Beijing) Co. Ltd., Hologic Medicor GmbH, Hologic Medicor Suisse GmbH, Hologic Netherlands B.V., Hologic Nordic Holdings Oy, Hologic Singapore Pte. Ltd, Hologic Suisse SA, Hologic Surgical Products Costa Rica S.R.L., Hologic Sweden AB, Hologic Taiwan Ltd., Hologic UK Finance Ltd., Hologic US Finance Co LLC, Interlace Medical, Mobidiag Oy, Mobidiag Oy., Mobidiag UK Ltd., NXT-Dx SCRL, Navigation Three Limited, R2 Technology, Sentinelle Medical, Somatex (HK) Limited, Somatex Medical Technologies GmbH, Somatex Medical Technologies GmbH., Somatex USA Inc., SuperSonic Imagine (Shanghai) Medical Devices Co. Ltd., SuperSonic Imagine GmbH, SuperSonic Imagine HK Ltd, SuperSonic Imagine Ltd, SuperSonic Imagine SA, SuperSonic Imagine Srl, Suros Surgical Systems, Suros Surgical Systems Inc., TCT International, TCT International Co. Ltd., Third Wave Technologies, and Tridaho LLC.
Read More
This page (NASDAQ:HOLX) was last updated on 2/24/2024 by MarketBeat.com Staff